The coexistence of y-aminobutyric acid (GABA), glutamate decarboxylase (GAD), and cholecystokinin (CCK)-or somatostatin-immunoreactive material in the same neurons was studied in the hippocampus and visual cortex of the cat. One-micrometer-thick serial sections of the same neuron were reacted to reveal different antigens by the unlabeled antibody enzyme method. All CCK-and somatostatin-immunoreactive neurons in the cortex and all CCK-immunoreactive and the majority of somatostatin-immunoreactive neurons in the hippocampus that could be examined in serial sections were also immunoreactive for GABA. In neurons that were immunoreactive for GAD it was often possible to demonstrate immunoreactivity for one of the peptides as well as for GABA. GABA-immunoreactive neurons, as revealed by an antiserum to GABA, were present in all layers of the cortex and hippocampus, and their shape, size, and distribution were similar to GAD-immunoreactive neurons. All GAD-immunoreactive neurons were also positive for GABA, but the latter staining revealed additional neurons. CCK/GABAand somatostatin/GABA-immunoreactive neurons were present mainly in layers II and upper III and in layers V and VI in the visual cortex. CCK/GABAimmunoreactive neurons were most frequently present in the strata oriens, pyramidale, and moleculare of the hippocampus and in the polymorph cell layer of the dentate gyrus. Somatostatin/GABA-immunoreactive neurons were localized mainly in the stratum oriens and in the hilus of the fascia dentata. The two peptides could not be found in the same neuron. The majority of neurons that were GABA immunoreactive did not stain for either peptide.
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The presence of CCK-and somatostatin-immunoreactive material in GABAergic cortical neurons raises the possibility that neuroactive peptides affect GABAergic neurotransmission.
There is increasing evidence from structural studies that the GABAergic interneurons in the neocortex and hippocampus are a heterogeneous population with regard to their morphology and synaptic connections (see Ribak, 1978; Ribak et al., 1981;  Wolff and Chronwall, 1982; Freund et al., 1983; Hendry et al., 1983a; Somogyi et al., 1983a Somogyi et al., , 1984 . Thus, one type of identified interneuron, the axoaxonic cell, which terminates exclusively on the axon initial segment of pyramidal cells, has now been shown to contain glutamate decarboxylase (GAD) (Freund et al., 1983) , the enzyme synthesizing y-aminobutyric acid (GABA).
Because the axoaxonic cell gives synapses to only the initial segment, other GAD-containing boutons which have been shown to terminate on the soma, dendrites, and spines of the postsynaptic cells (Ribak, 1978; Ribak et al., 1981; Freund et al., 1983; Hendry et al., 1983a; Somogyi et al., 1983a, d ) must originate from other GABAergic neurons. Indeed there is strong indirect evidence that cortical basket cells, which give a high proportion of their synapses onto the perikarya of other neurons (Martin et al., 1983; Somogyi et al., 1983b) , are also GABAergic (for discussion, see Hendry et al., 1983; Somogyi et al., 198313) . Furthermore, immunocytochemical studies on the distribution of GAD in cortex (Ribak, 1978; Hendrickson et al., 1981; Freund et al., 1983; Houser et al., 1983; Somogyi et al., 1983a) and hippocampus (Ribak et al., 1981; Oertel et al., 1982; Kohler and Chan-Palay, 1983a; Seress and Ribak, 1983; Somogyi et al., 1983d) show that the immunoreactive neurons differ greatly in the shape, size, and distribution of their perikarya and dendrites.
The question arises whether these differences in structural properties and synaptic connections are also accompanied by biochemical differences between the different types of GABAergic neurons. It would also be important to know whether there are differences in the molecular events when GABA exerts its action at such diverse postsynaptic sites as dendritic spines or shafts, the perikaryon, or the axon initial segment of many types of neurons.
The first indication that interneurons with smooth and sparsely spinous dendrites, which up to very recently have been thought to be GABAergic, may be heterogeneous biochemically came with the demonstration of immunoreactive material resembling several neuroactive peptides, among them somatostatin (Finley et al., 1978; Bennett-Clarke et al., 1980; Krisch, 1980; Feldman et al., 1982; Kohler and Chan-Palay, 1982b, 1983a; McDonald et al., 1982a; Shiosaka et al., 1982; Sorensen 1982; Morrison et al., 1983) and cholecystokinin (CCK) (Innis et al., 1979; Larsson and Rehfeld, 1979; Vanderhaeghen et al., 1980; Emson and Hunt, 1981; Greenwood et al., 1981; Handelmann et al., 1981; Kohler and Chan-Palay, 1982a; McDonald et al., 198213; Hendry et al., 1983b; Peters et al., 1983) in cortical neurons morphologically very similar to those containing GAD (see above). Thus, either there are different interneuron populations, some containing GABA, others containing peptides, or alternatively some GABAergic neurons could contain more than one neuroactive substance, as do other neurons in the central and peripheral nervous system (see Lundberg and Hokfelt, 1983) .
We have tested the latter hypothesis in the hippocampus and visual cortex by immunohistochemistry, reacting different sections of the same neuron for the demonstration of GABA on the one hand and for either CCK or somatostatin on the other. The hippocampus and the visual cortex were chosen because, although they have very different functions, the structure and function of GABAergic neurons have been studied most extensively in these two areas, and at least some of the organizational principles have been found to be similar.
Materials and Methods
Preparation of animals and tissue sections. Three adult cats were used. Two of the animals were anesthetized and injected with colchicine (BDH Chemicals, 6 pg/pl, dissolved in artificial cerebrospinal fluid) unilaterally into the hippocampus and visual cortex as described previously (Somogyi et al., 1983d were reacted with glutaraldehyde, lo%, in sodium nhosahate buffer. 0.1 M. DH 6.9. at 56°C for 20 hr. The beads were washed extensively with' water; then sodium phosphate buffer, 0.1 M, pH 7.7, before a l.O-ml aliquot, was reacted with the antigens dissolved in the sodium phosphate buffer (pH 7.7) for 20 hr at room temperature. In each case, antigen of the highest purity available was used and, where possible, was obtained from a supplier different from the one used to prepare the immunogens.
The following quantities of antigen were each reacted with 1.0 ml of packed wet gel; GABA, 100 pmol (Serva Feinbiochemica); CCK-8, 10 nmol (Sigma); and somatostatin, 100 nmol (Sigma).
Excess aldehyde groups were blocked by incubation with 1 M ethanolamine, pH 7.7, for 120 min. Beads coupled with antigen were then washed-extensively with TPBS before equilibration with TPBS containing 1% normal sheen serum. Eaual auantities of gel beads and diluted a&erum were then incubated by rotation at 4°C for 16 to 18 hr. Antisera were diluted as follows: anti-GABA 7, l/1000; anti-CCK, l/100; antisomatostatin, l/50, so that after mixing with beads the sera were at, or above, their working strength. Antisera were separated from the beads by centrifugation (5000 to 8000 x g.,.min) before application to the tissue sections. Immunostaining of neuronal cell bodies for CCK and somatostatin was restricted mostly to the cytoplasm (Figs. 2, D and G, 3C, 5, A, C, and G, and 7B), but in strongly immunoreactive neurons the nucleus could also be slightly stained (Fig.  6C ). Small immunoreactive dots were also observed in the sections reacted for peptides, but they were much fewer than in the sections reacted for GABA. In the sections from the normal cat, peptide-immunoreactive perikarya were very rare and only weakly stained. Coichicine injection greatly increased both the number of immunoreactive neurons and the intensity of the staining. There was a difference in the staining for the two peptides. Immunoreactivity for CCK was much stronger in both the visual cortex and the hippocampus and homogeneously filled the cytoplasm.
Somatostatin-immunoreactive neurons were often stained only in small patches resembling the position of the Golgi apparatus in the perikarya.
Immunostaining of neuronal perikarya for GAD was also weak in the nontreated animal. Colchicine treatment increased the intensity of the staining, but it was still usually weaker than with the other antisera.
Specificity of the immunostaining. Under our incubation conditions all peroxidase reaction endproduct was due to immunostaining.
The staining of neurons with antisera to GABA, CCK, or somatostatin was completely abolished when the antiserum was preincubated with the homologous antigen bound to polya&amide beads. This was also true at the level of single cells. When a cell that was known to contain the antigen, from the reaction in a consecutive section, was tested (Figs. 2, E and F, and 5, B and E), the reaction was completely abolished by preadsorption of the test antiserum by homologous antigen. The peptides used for the adsorption were of a different make from those used for immunization. of the molecular species responsible for the staining cannot be determined. Therefore, all staining will be referred to as immunoreactivity resembling the antigen used for immunization. Distribution of GABA-immunoreactive neurons in the visual cortex. A coronal section of the lateral gyrus is illustrated in Figure 1 . Immunoreactive neurons were present in all layers and, in addition, scattered neurons were found in the white matter. The delineation of the layers was difficult in the specimens; therefore, only the border of layer I was indicated in Figure 1 . There was no obvious pattern in the distribution of neurons in the tangential direction. Layers II and III contained the highest density of GABA-immunoreactive neurons, and their number decreased toward the deeper layers (Fig. 1) . The shape and size of the immunoreactive neurons varied greatly both within and between the layers, but on the basis of the stained perikarya their types could not be determined.
Presence of immunoreactive peptides in GABAergic neurons of the visual cortex. Incubating serial sections of the same neuron for different antigens revealed that some GABA-immunoreactive neurons also contained CCK- (Fig. 2 , D and G) and somatostatin-immunoreactive (Fig. 3C ) material. All peptide-immunoreactive neurons studied so far in the visual cortex were found to contain GABA immunoreactivity as well. Neurons could not be stained for both peptides, although immunoreactive neurons for CCK or somatostatin show a similar laminar distribution.
The distribution and relative abundance of the neurons which were immunoreactive for both a peptide and GABA are shown in Figure 1 . Most of them were situated in layer II and upper layer III. Scattered neurons were found in layers IV and V, and they again became more numerous in layer VI. Somatostatin-immunoreactive neurons were also frequently present in the white matter. Under our incubation conditions somatostatin-immunoreactive neurons were much more numerous than neurons immunoreactive for CCK. Because the demonstration of peptides in most perikarya depended on colchicine treatment, no attempt was made to count the immunoreactive neurons. The immunoreactive peptides were found most frequently in small round or elliptical GABA-containing neurons with sizes around 8 to 12 pm. Fusiform CCK-immunoreactive neurons were also observed with their long axis oriented perpendicular to the pia. The GABAergic neurons which contained somatostatin-immunoreactive material in the white matter were also spindle shaped with their long axis parallel to the course of the fibers.
Distribution of GABA-immunoreactiue neurons in the hippocampus. All layers of the hippocampus and the dentate gyrus were found to contain GABAergic neurons (Fig. 4) . The stratum radiatum contained fewer neurons than the stratum oriens and stratum moleculare of the hippocampus (Figs. 4 and 6A) . The sizes and shapes of the neurons varied considerably. Small neurons were most frequently present in the stratum pyramidale, stratum moleculare, and immediately below and above the granule cell layer of the dentate gyrus. Large GABA-immunoreactive neurons were most common in the stratum oriens, the alveus, the white matter leading to the fimbria, and the hilus of the dentate gyrus. The proportion of GABA-immunoreactive neurons was similar in the colchicine-injected and in the untreated animals. Figure 1 . Camera lucida tracing of a l-pm-thick section of the striate cortex in the lateral gyrus of the cat. Dorsal is to the top and medial is to the right. Neurons immunoreactive for GABA only (dots), those immunoreactive for both CCK and GABA (asterisks), and those immunoreactive for both somatostatin and GABA (triangles) are indicated. The neurons represented by dots and triangles are each from a single section. The neurons represented by asterisks were pooled from a representative sample of 10 serial sections to illustrate their intracortical distribution. Z, layer I; p, pia; wm, white matter. Scale = 1 mm.
Presence of immunoreactive peptides in GABAergic neurons of the hippocampw.
CCK immunoreactivity could be demonstrated in some GABA-containing neurons most frequently in and immediately below the pyramidal cell layer, in the stratum moleculare, and in the polymorph cell layer below the granule cells in the dentate gyrus (Figs. 4 to 6 ). Occasional neurons were found in the stratum oriens and stratum radiatum. All CCK-immunoreactive neurons from which serial sections could be obtained in the GABA-reacted material were also stained for GABA. The neurons were mostly small to medium size (Figs. 5, A to F, and 6, B and C), but in the polymorphic cell layer some large neurons were also observed (Fig. 5, G to I) . Somatostatin-immunoreactive neurons were localized mainly to the lower half of stratum oriens and to the hilus of the dentate gyrus (Fig. 4) . They were medium to large in size, 10 to 25 pm in diameter, and frequently elongated in shape with thick dendrites originating from opposing poles of the neuron (Fig. 7A) . Most but not all of the somatostatin-immunoreactive neurons could be shown to contain GABA immunoreactivity (Fig. 7) . In general, GABA immunoreactivity was weaker in these neurons than in the CCK-immunoreactive ones. Somatostatin and CCK immunoreactivity was never observed in the same neurons.
Presence of GABA, GAD, and peptide immunoreactivity in the same neurons. All GAD-immunoreactive neurons which could be found in serial sections in the hippocampal formation and in the visual cortex were also immunoreactive for GABA. In addition, GABA immunohistochemistry revealed neurons which did not show staining with the anti-GAD serum. In general, perikaryal staining for GAD was weak; thus it is likely that some GAD-containing neurons were not detected. In many cases GABA, GAD, and either CCK (Fig. 7, G to I 
Discussion
The results of the present study using postembedding immunohistochemistry are in good agreement with previous studies using other methods for the localization of GABAergic and peptide-immunoreactive neurons. GABAergic neurons have been demonstrated in the hippocampus of the rat (Ribak et al., 1978; Oertel et al., 1982; Kijhler and Chan-Palay, 1983a; Seress and Ribak, 1983) and cat (Somogyi et al., 1983d) and in the neocortex of the rat (Ribak, 1978) , cat (Freund et al., 1983; Somogyi et al., 1983a) , and monkey (Hendrickson et al., 1981; Hendry et al., 1983b; Houser et al., 1983 ) using GAD immunohistochemistry.
The antiserum raised against GABA and used in the present study stains similar neurons and in distributions similar to those that have been shown to contain GAD (Freund et al., 1983; Somogyi et al., 1983a, d) in the cat.
An antiserum to GABA was also used in a recent study for the localization of GABAergic neurons (Storm-Mathisen et al., 1983) , and GABA-like immunoreactivity was reported in nonpyramidal cells in cortical areas.
The distribution of CCK-and somatostatin-immunoreactive neurons also followed the same pattern as previously shown in both hippocampus (Finley et al., 1978 (Finley et al., , 1981b Vanderhaeghen et al., 1980; Greenwood et al., 1981; Handelmann et al., 1981;  Figure 2. Illustration of the presence of both GABA and CCK immunoreactivity in the same cortical neuron. A, Light micrograph of a l-pmthick section of area 17 in the lateral gyrus of the cortex. Darkly stained GABA-immunoreactive neuronal perikarya appear in all layers (I to VI). The boxed area from this section is shown at higher magnification in B. B to G, Consecutive serial l-pm-thick sections incubated with antiserum to GABA (B ), with antiserum to GABA that had been preincubated with CCK coupled to polyacrylamide beads (C), with antiserum to CCK (D), with antiserum to GABA that had been preincubated with GABA coupled to polyacrylamide beads (E), with antiserum to CCK that had been preincubated with CCK coupled to polyacrylamide beads (P), and with antiserum to CCK preincubated with GABA coupled to polyacrylamide beads (G). One neuron (open arrows) is immunoreactive for both GABA and CCK while another one (horizontal solid arrows) is immunoreactive for GABA only. Other GABA-immunoreactive neurons (long arrows in B and C) could not be followed in all of the sections. Neurons (one indicated by the asterisk) which are not immunoreactive for either substance are also present. GABA-immunoreactive dots (small arrows), probably nerve terminals, are seen in B and C. Capillary (c) serves as landmark. Scales: A, 100 pm; B to G, 20 pm. . Camera lucida tracing of a l-pm-thick section of the cat hippocampus cut approximately perpendicular to its long axis. Neurons immunoreactive for GABA (dots), those immunoreactive for both GABA and CCK (asterisks), and those immunoreactive for both GABA and somatostatin (triangles) are indicated. The neurons derive from four consecutive sections, two of which were reacted to reveal GABA, one for CCK, and one for somatostatin. F, fimbria; H, hilus, SG, stratum granulosum; SM, stratum moleculare; SO, stratum oriens; SP, stratum pyramidale; SR, stratum radiatum. Scale: 500 ym. Feldman et al., 1982; Kohler and Chan-Palay, 1982a, b; Morrison et al., 1982) and the neocortex (Finley et al., 1978 (Finley et al., , 1981b Innis et al., 1979 , Krisch, 1980 Vanderhaeghen et al., 1980; Emson and Hunt, 1981; McDonald et al., 1982a, b; Shiosaka et al., 1982; Sorensen, 1982; Vincent et al., 1982; Hendry et al., 1983b; Morrsion et al., 1983; Peters et al., 1983) . Neuroactive peptides in GABAergic neurons. The main finding of the present study is that GABAergic neurons contain neuroactive peptides. The GABAergic neurons which contain either somatostatinor CCK-immunoreactive material constitute a small proportion of all GABA-immunoreactive neurons in the cortical areas studied. Their shape and size indicate that they are probably subpopulations of nonpyramidal cells with smooth or sparsely spiny dendrites.
Indeed, pre-embedding immunohistochemical studies (see above), which reveal some of the dendritic and/or axonal processes of the peptide-immunoreactive neurons, show that somatostatin and CCK immunoreactivity is present (separately) in a variety of nonpyramidal neurons known from Golgi studies. For example, on the basis of dendritic and axonal morphology, some CCK-immunoreactive neurons have been indirectly correlated with bipolar cells in the visual cortex of rat and monkey (Peters et al., 1983 , Hendry et al., 1983b and with double bouquet cells in the cat's visual cortex (Somogyi and Cowey, 1984) . At present (even with the best pre-embedding immunohistochemical material) the category of nonpyramidal cell to which the peptide-immunoreactive neurons belong cannot be established. It is possible that they do not comprise a single category as delineated by synaptic connections.
Two categories of GABAergic interneurons which have been characterized in detail with respect to their synaptic connections can be excluded as candidates containing CCK or somatostatin.
The axoaxonic cells of both the visual cortex (Fairen and Valverde, 1980; Somogyi et al., 1982; Freund et al., 1983) and hippocampus (Somogyi et al., 1983c, d) Emson and Hunt, 1981) , peptide Y- (Loren et al., 1979; Vincent et al., 1982) , and enkephalin- (Finley et al., 1981a; Gall et al., 1981; Khachaturian et al., 1983) immunoreactive material have been shown to be present in nonpyramidal neurons resembling those that are immunoreactive for GAD and GABA. It remains to be established whether any of the latter peptides are in fact present in GABAergic neurons. Molecular nature of immunoreactive material. It should be pointed out that, although we have shown the presence of CCKand somatostatin-immunoreactive material in the perikarya of GABA-containing neurons, it is not entirely clear what molecular species are present in the perikarya or are released at the terminals of the neurons. Chromatography of brain homogenates shows that besides significant amounts of triacontatriapeptide (CCK-33), dodecapeptide (CCK-12), and tetrapeptide (CCK-4), the bulk of the CCK-immunoreactive material in the brain is the octapeptide (CCK-8) (Dockray, 1976,198O; Muller et al., 1977; Dockray et al., 1978; Rehfeld, 1978; Larsson and Rehfeld, 1979; Beinfeld, 1981) . The octapeptide is also released from brain slices (Emson et al., 1980) and from cortical synaptosomes (Pignet et al., 1979) in a calcium-dependent manner. Thus, CCK-8 is a good candidate to act at the GABAergic synapses. Somatostatin is probably present in the neurons as part of a larger precursor molecule (Rorstad et al., 1979; Zyznar et al., 1979; Pate1 et al., 1981) . This is supported by the finding in both perikarya and boutons in cortex (Lechan et al., 1983; Morrison et al., 1983) and hippocampus (Morrison et al., 1982) of immunoreactivity specific for a prosomatostatin peptide sequence which is distinct from somatostatin-14.
Thus, it is not yet known which peptide segment from the prosomatostatin sequence may have relevance to GABAergic transmission. Somatostatin-immunoreactive material can also be released in Figure 5 . A to F, Coexistence of GABA and CCK immunoreactivity in the same neuron in the outer molecular layer of the dentate gyrus. Consecutive l-pm-sections were reacted with antiserum to CCK preincubated with GABA coupled to polyacrylamide beads (A); antiserum to CCK preincubated with CCK coupled to polyacrylamide beads (B); antiserum to CCK (C); antiserum to GABA preincubated with CCK coupled to polyacrylamide beads (D); antiserum to GABA preincubated with GABA coupled to polyacrylamide beads (E); and antiserum to GABA (F). The same neuron (open arrows) and capillary (asterisk) are labeled. G to Z, Consecutive serial sections of the dentate gyrus. A large pyramidalshaped neuron (asterisk) in the polymorphic cell layer above stratum granulosum (SG) is immunoreactive for CCK (G), glutamate decarboxylase (H), and GABA (I). Granule cells (one marked by arrow) are not immunoreactive for any of these substances. Scales: A to F, 10 pm; G to Z, 10 Irm.
uitro from extrahypothalamic brain tissue including the cortex (Iversen et al., 1980; Lee and Iversen, 1981) .
Possible functional implications. The use of serial sections made it possible to show that most, if not all, of the somatostatin-and CCK-immunoreactive neurons also contain GABA. The significance of this finding is Z-fold. First, it demonstrates that in addition to their differences in morphology and synaptic connectivity, cortical GABAergic neurons are also heterogeneous biochemically.
Second, the presence of neuroactive peptide-immunoreactive material in neurons which also contain an amino acid transmitter raises the possibility that the peptides and GABA are stored and could be released together at the terminals of these neurons. Indirect evidence does indicate that GABA and CCK or somatostatin might be present in the same nerve terminals.
Thus CCK immunoreactivity has been demonstrated in boutons surrounding the perikarya of pyramidal cells in the hippocampus (Larsson and Rehfeld, 1979; Greenwood et al., 1981) and also in the cortex (Kohler and Chan-Palay, 1982a; Hendry et al., 1983b; Peters et al., 1983 ; our unpublished observations in the cat).
Similarly, somatostatin-immunoreactive pericellular networks which could represent nerve terminals have been demonstrated in both areas (Petrusz et al., 1977; Feldman et al., 1982; Morrison et al., 1982; Kohler and Chan-Palay, 1983b) . At the same time, most, if not all, boutons around the perikarya of pyramidal neurons in the visual cortex and hippocampus have been shown to contain GAD (Freund et al., 1983; Somogyi et al., 1983d) ; thus, it is likely that the CCK-and somatostatinimmunoreactive boutons are among the GABAergic terminals. This is further supported by the similarity of the synaptic junctions, as both CCK- (Hendry et al., 198313) and GADimmunoreactive (Ribak, 1978) boutons form Gray's type II synaptic contacts (Gray, 1959) in the cortex. However, without double staining at the electron microscopic level, it cannot yet be excluded that the CCK-, somatostatin-, or GAD-and GABAimmunoreactive axosomatic boutons originate from two distinct neuronal populations, or that the neurons receiving them belong, in fact, to two separate populations.
Previous pre-embedding immunohistochemical studies which revealed the morphology of peptide-containing neurons in more detail indicate that the CCK-and somatostatin-immunoreactive populations are different (McDonald et al., 1982a, b; Morrison et al., 1982 Morrison et al., , 1983 Hendry et al., 198313; Peters et al., 1983) . Furthermore, we have not been able to demonstrate the presence of the two peptides in the same neuron which, together with their different distribution in the hippocampus, implies that they play different roles in the circuitry of cortical areas. As has been mentioned earlier, different types of identified GABAergic neurons also differ in their efferent synaptic connections (for discussion, see Freund et al., 1983; Hendry et al., 1983a; Somogyi et al., 1983d) . It is noteworthy that when the input from the lateral geniculate nucleus to morphologically and physiologically identified neurons in the visual cortex was studied, it was found that both pyramidal and nonpyramidal cells were activated mainly by either the fast (Y) or the slow (X) stream of afferents (Martin and Whitteridge, 1982, 1984) . It is conceivable that the two streams require different local processing apparatus, each of which may have its unique set of GABAergic neurons containing different peptides. In any case, the question arises, why should they contain different peptides?
One possible explanation is that different parts of the postsynaptic neuron, such as the axon initial segment, the soma, and the proximal and distal dendrites which all receive GABAergic input, have different GABA receptors (see Alger and Nicoll, 1982; Bowery et al., 1983) . The differences in the receptors could be brought about by the modulatory action of peptides released from the GABAergic nerve terminals and acting on binding sites related to the GABA receptor. Indeed, the receptor complex for GABA has several modulatory binding sites. Thus, separate binding sites for picrotoxin, benzodiazepines, and barbiturates are probably associated with the GABA receptor ionophore complex (see Olsen 1982; De Feudis, 1983) . The endogenous substrates for these binding sites are not known; however, for the benzodiazepine receptor a polypeptide has been suggested (Guidotti et al., 1983) . It would be interesting to see how somatostatinand CCK-related peptides modify the action of GABA agonists and antagonists acting on the different binding sites associated with the GABA receptor complex.
Possible interactions at the receptors. If one assumes that CCK-and somatostatin-related peptides are released from the same neuron that releases GABA and they act on the same postsynaptic target, what could be their effect? GABA on its own is known to increase the conductance for chloride ions which leads to hyperpolarization and inhibition of neurons in both the neocortex and the hippocampus (Biscoe and Straughan, 1966; Krnjevic and Schwartz, 1967 Renaud et al., 1975; Phillis and Kirkpatrick, 1980) and excitatory (Ioffe et al., 1978; Phillis and Kirkpatrick, 1980) responses were also reported for cortical neurons, and these apparent discrepancies were recently discussed in relation to prominent depolarizing and excitatory responses observed in cortical neurons in tissue culture (Delfs and Dichter, 1983) . Both CCK-8 and CCK-4 have been found to cause depolarization and excitation in the in vitro hippocampal slice preparation (Dodd and Kelly, 1981) . Excitatory responses were also observed in the cortex on those neurons which responded to iontophoretically applied CCK (Ishibashi et al., 1979; Phillis and Kirkpatrick, 1980; Lamour et al., 1983) . However, in the nucleus tractus solitarius (Morin et al., 1983) and in 2.8% of cortical neurons tested (Ishibashi et al., 1979) , inhibitory responses to CCK-8 were also reported. The predominantly excitatory effects observed for somatostatin and CCK in cortical structures and the inhibitory effect exerted by GABA are at first sight contradictory if these substances are stored and released by the same nerve terminals. However, as pointed out by Kelly (1982) , the iontophoretic application of peptides is only a first step for the analysis of their action. The development of agonists and antagonists will be necessary to clarify the mechanisms involved. Agonists and antagonists are available for the GABA receptors and, assuming that the peptides and GABA interact at the postsynaptic site, the influence of the peptides could be studied both in iontophoretic studies and in in vitro binding experiments.
Coexistence of other peptides and neurotransmitters. Several peptides have now been demonstrated to be present in neurons known to contain smaller neurotransmitter molecules (see Lundberg and Hokfelt, 1983) . Neurons which are throught to be GABAergic have been shown to contain motilin in the cerebellum (Chan-Palay et al., 1981) , somatostatin in the reticular nucleus of the thalamus (Oertel et al., 1982 (Oertel et al., , 1983 , and serotonin in the dorsal raphe nucleus (Belin et al., 1981) . The functional significance of these other molecules and of the ones demonstrated in the present study in relation to the action of GABA is not known. In other situations where a neuroactive peptide coexists with another transmitter, there is evidence of several kinds of mutual interaction, both pre-and postsynaptic. For example, one of the substances can modulate the release of the other; this has been shown for dopamine and CCK in the striatum (Starr, 1982; Meyer and Krauss, 1983 ) and cerebral cortex (Klaff et al., 1982) . A different presynaptic action has been proposed for substance P in the spinal cord, where it may attenuate the autoinhibition of serotonin release by serotonin (Mitchell and Fleetwood-Walker, 1981) . In view of our results, it would be of interest to know whether GABA and CCK, or GABA and somatostatin, can affect each other's release from nerve terminals.
The studies so far reported have not distinguished between actions on cell bodies and those on nerve endings. Thus, Robbins et al. (1982) found that GABA inhibits the spontaneous release of somatostatin-immunoreactive material from cultured neurons derived from the cortex, whereas Sheehan and De Belleroche (1983) found that CCK increased the K+-evoked release of labeled GABA from slices of the cortex. Furthermore, since there is evidence of GABA autoreceptors (see Brennan, 1982 for references), it would be worth testing whether CCK or somatostatin can influence these receptors. Interaction at the postsynaptic site has also been demonstrated for both the serotonin/substance P (Agnati et al., 1983) and the CCK/dopamine (Fuxe et al., 1981) systems. The hippocampus and cerebral cortex, where we have shown the coexistence of GABA with CCK or somatostatin, are among the best studied brain regions not only with respect to the electrophysiological actions of these peptides but more particularly with respect to the mechanisms and functions of GABAmediated inhibition.
Accordingly, these regions might profitably be explored in a search for possible subtle interactions between GABA and the two peptides that would give a functional meaning to our morphological observations. References Agnati, L. F., K. Fuxe, F. Benfenati, I. Zini, and T. Hckfelt (1983) The functional role of coexistence of 5-HT and substance P in bulbosninal 5-HT neurons. Substance P reduces affinity and increases dens& of 
